Drug intelligence / Profile preview

antrocin

Development stage
Preclinical
Modality
Small Molecules
Administration
Oral, Intraperitoneal
01

Overview

Antrocin is a **naturally occurring sesquiterpene lactone** isolated primarily from the medicinal mushroom *Antrodia cinnamomea*. It has demonstrated **antiproliferative effects against multiple cancer cell types** (including breast, lung, prostate, and bladder cancers), exerting its effects by inhibition of tumor-promoting signaling pathways such as **PI3K/AKT, MAPK, JAK2/STAT3, IGF-1R, β-catenin, Notch1, and Akt**[1][2][3][8][10]. Preclinical studies show it can sensitize cancer cells to radiotherapy and potentiate the effect of chemotherapeutics like paclitaxel[2][3]. Antrocin also exhibits strong anti-oxidant and antimutagenic activities[1]. It has been evaluated for genotoxicity and oral toxicity in animal studies, showing a lack of significant toxicity at therapeutic reference doses[1]. Synthetic routes for antrocin as well as its isolation from fungal sources have been described[1][6][10][11].

02

Targets

AKT (RAC-alpha serine/threonine-protein kinase)IGF-1R (Insulin-like growth factor 1 receptor)JAK2 (Janus kinase 2)MAPK3 (Mitogen-activated protein kinase 1)NOTCH (Neurogenic locus notch homolog protein 3)PI3K (Phosphoinositide-3-kinase regulatory subunit 6)STAT3 (Signal Transducer and Activator of Transcription 3)CTNNB1 (Beta-catenin)

Beyond the preview

Go deeper on antrocin.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from study design and recruitment through results.

  • Trial phase
  • Status
  • Readouts

Indications & development

Explore development by indication, patient population, and geography.

  • Indications
  • Development status
  • Countries

Licensing & deals

Trace asset ownership, licensing agreements, and commercial partnerships.

  • Partners
  • Deal terms
  • Milestones

Patents & exclusivity

Explore the patent landscape and regulatory exclusivity around an asset.

  • Patents
  • Expiration dates
  • Exclusivity

Competitive landscape

Compare development programs by target, modality, and indication.

  • Competing assets
  • Targets
  • Development stage

Research & analysis

Connect source evidence and development news to your research questions.

  • Publications
  • News
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on antrocin.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call